ES2655913T3 - Composición probiótica para la salud oral - Google Patents
Composición probiótica para la salud oral Download PDFInfo
- Publication number
- ES2655913T3 ES2655913T3 ES11749151.4T ES11749151T ES2655913T3 ES 2655913 T3 ES2655913 T3 ES 2655913T3 ES 11749151 T ES11749151 T ES 11749151T ES 2655913 T3 ES2655913 T3 ES 2655913T3
- Authority
- ES
- Spain
- Prior art keywords
- oral
- strains
- none
- composition
- cfu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title abstract description 17
- 239000006041 probiotic Substances 0.000 title description 5
- 235000018291 probiotics Nutrition 0.000 title description 5
- 230000000529 probiotic effect Effects 0.000 title description 3
- 240000001929 Lactobacillus brevis Species 0.000 abstract description 9
- 240000006024 Lactobacillus plantarum Species 0.000 abstract description 4
- 235000013957 Lactobacillus brevis Nutrition 0.000 abstract description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 abstract description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 241000191998 Pediococcus acidilactici Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 241000186604 Lactobacillus reuteri Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000194024 Streptococcus salivarius Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000000668 oral spray Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 230000002053 acidogenic effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical class OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004690 coupled electron pair approximation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- SUYRLXYYZQTJHF-VMBLUXKRSA-N dalfopristin Chemical compound O=C([C@@H]1N(C2=O)CC[C@H]1S(=O)(=O)CCN(CC)CC)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC2=CO1 SUYRLXYYZQTJHF-VMBLUXKRSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000000001 dental powder Substances 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 1
- 229940025294 hemin Drugs 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 239000008375 oral care agent Substances 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 229940041678 oral spray Drugs 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- -1 sachets Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/24—Lactobacillus brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10173286 | 2010-08-18 | ||
| EP10173286A EP2420580A1 (en) | 2010-08-18 | 2010-08-18 | Probiotic composition for oral health |
| PCT/EP2011/064173 WO2012022773A1 (en) | 2010-08-18 | 2011-08-17 | Probiotic composition for oral health |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2655913T3 true ES2655913T3 (es) | 2018-02-22 |
Family
ID=42727422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11749151.4T Active ES2655913T3 (es) | 2010-08-18 | 2011-08-17 | Composición probiótica para la salud oral |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9511102B2 (enExample) |
| EP (2) | EP2420580A1 (enExample) |
| JP (1) | JP5879349B2 (enExample) |
| CN (1) | CN103298924B (enExample) |
| AU (1) | AU2011290705B2 (enExample) |
| BR (1) | BR112013003761B1 (enExample) |
| DK (1) | DK2606155T3 (enExample) |
| ES (1) | ES2655913T3 (enExample) |
| MX (1) | MX346458B (enExample) |
| RU (1) | RU2584610C2 (enExample) |
| WO (1) | WO2012022773A1 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5904028B2 (ja) * | 2012-06-19 | 2016-04-13 | ライオン株式会社 | 乳酸菌及びその培養由来物、ならびにこれらを含有する組成物 |
| JP6351985B2 (ja) * | 2013-01-30 | 2018-07-04 | 株式会社 ソーシン | 口腔用組成物 |
| EA034376B1 (ru) | 2013-07-05 | 2020-01-31 | Интегра Медикал Инк. | Композиции для оздоровления полости рта |
| CN103627637A (zh) * | 2013-11-29 | 2014-03-12 | 天津大学 | 一种乳酸片球菌菌株冷冻干燥制剂的制备方法 |
| US11173018B1 (en) * | 2015-04-16 | 2021-11-16 | Able Biomedical Devices, Llc | Oral hygiene device |
| EP3117822A1 (en) * | 2015-07-17 | 2017-01-18 | AB-Biotics, S.A. | Self-film-forming composition for oral care |
| CN106822007B (zh) | 2015-09-11 | 2021-12-31 | 西姆莱斯股份公司 | 口服制剂 |
| CN105193859A (zh) * | 2015-09-25 | 2015-12-30 | 南昌大学 | 一种天然口腔细菌移植在口腔疾病治疗中的应用 |
| CN105193857A (zh) * | 2015-09-25 | 2015-12-30 | 南昌大学 | 一种人工培养口腔细菌移植在口腔疾病治疗中的应用 |
| CN109803666A (zh) * | 2015-11-30 | 2019-05-24 | 医迈霖科技公司 | 包括益生菌的组合物及其使用方法 |
| US11020441B2 (en) | 2016-01-19 | 2021-06-01 | Symrise Ag | Probiotics for use as anti-inflammatory agents in the oral cavity |
| GB201600975D0 (en) * | 2016-01-19 | 2016-03-02 | Probi Ab | Novel strain of probiotic bacteria and compositions and uses thereof |
| EP3196318A1 (en) | 2016-01-19 | 2017-07-26 | Symrise AG | Probiotics for altering the composition of oral biofilms |
| WO2017173240A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| JP2019510036A (ja) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物 |
| MX379324B (es) * | 2016-10-03 | 2025-03-11 | Ab Biotics Sa | Bacterias del ácido láctico tolerantes a antisépticos |
| EP3544575A1 (en) | 2016-11-23 | 2019-10-02 | GOJO Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| EP3351259A1 (en) | 2017-01-18 | 2018-07-25 | Symrise AG | Probiotics for aggregation with disease-associated species in the oral cavity |
| US11304985B2 (en) * | 2017-03-10 | 2022-04-19 | Biohm Health Llc | Compositions and methods for promoting a healthy microbial flora in a mammal |
| JP2019025011A (ja) * | 2017-07-31 | 2019-02-21 | 株式会社グリーンエッセンス | フロスホルダー及びフロス |
| WO2020001747A1 (en) | 2018-06-26 | 2020-01-02 | Symrise Ag | Lactobacillus plantarum for skin care |
| CN108486022B (zh) * | 2018-07-02 | 2020-08-28 | 四川大学 | 一株抗龋病植物乳杆菌及其应用 |
| EP3822338A4 (en) * | 2018-09-30 | 2021-08-18 | Inner Mongolia Yili Industrial Group Co., Ltd. | LACTOBACILLUS PARACASEI ET-22 AND ITS USE |
| US11224760B2 (en) | 2019-04-16 | 2022-01-18 | The Procter & Gamble Company | Semisolid oral dispersions comprising bleaching agents |
| US11559473B2 (en) | 2019-04-16 | 2023-01-24 | The Procter & Gamble Company | Semisolid oral dispersions comprising active agents |
| US10849729B2 (en) | 2019-04-16 | 2020-12-01 | The Procter & Gamble Company | Multi-phase oral care compositions |
| US11712408B2 (en) | 2019-04-16 | 2023-08-01 | The Procter & Gamble Company | Semisolid oral dispersions comprising active agents |
| CN110122579A (zh) * | 2019-05-23 | 2019-08-16 | 光明乳业股份有限公司 | 一种由唾液链球菌制备发酵豆浆的方法及制备出的发酵豆浆与应用 |
| CN110122580A (zh) * | 2019-05-23 | 2019-08-16 | 光明乳业股份有限公司 | 一种由唾液链球菌制备发酵豆乳粉的方法及制备出的发酵豆乳粉与应用 |
| TWI733207B (zh) | 2019-10-02 | 2021-07-11 | 葡萄王生技股份有限公司 | 植物乳桿菌菌株、含其之組成物、其製造方法及其用於製備抑制或減少口腔病原菌之組成物的用途 |
| CN110713960B (zh) * | 2019-12-03 | 2021-02-05 | 嘉兴益诺康生物科技有限公司 | 植物乳杆菌ln66及在降低口臭风险产品中的应用 |
| CN111454862B (zh) * | 2020-04-12 | 2022-03-08 | 生合生物科技（扬州）有限公司 | 一种具有口腔保健功能的副干酪乳杆菌冻干粉、制备方法及应用 |
| CN111700916B (zh) * | 2020-08-10 | 2022-03-04 | 汤臣倍健股份有限公司 | 一种益生菌组合物及其应用 |
| CN112175884B (zh) * | 2020-10-29 | 2022-04-15 | 北京农学院 | 植物乳杆菌sd26及其产品和应用 |
| KR102360232B1 (ko) * | 2021-03-26 | 2022-02-09 | (주)바이오일레븐 | 구강질환 예방 또는 개선 효과를 가지는 락토바실러스 플란타룸 균주 및 이의 용도 |
| CN113957006B (zh) * | 2021-09-27 | 2022-09-30 | 微康益生菌(苏州)股份有限公司 | 一种植物乳杆菌n13及其在预防或治疗龋齿和牙周炎上的应用 |
| JP2023095346A (ja) * | 2021-12-24 | 2023-07-06 | サンスター株式会社 | 乳酸菌含有組成物 |
| AU2023233349A1 (en) | 2022-03-17 | 2024-10-10 | Kaneka Corporation | Glucuronidase activator, pharmaceutical composition, edible composition, and composition for oral application |
| CN114574405B (zh) * | 2022-05-05 | 2022-08-26 | 微康益生菌(苏州)股份有限公司 | 植物乳杆菌菌株wka86及其在制备防治口臭制品方面的用途与制品 |
| WO2025149376A1 (en) * | 2024-01-10 | 2025-07-17 | Biopolis, S.L. | Lactiplantibacillus plantarum strain and its oral health related uses |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2448865A1 (fr) * | 1979-02-16 | 1980-09-12 | Valpron Grpt Interet Economiqu | Procede de traitement de jus de pressage de produits vegetaux, notamment de luzerne, pour la production de proteines alimentaires et de divers aliments proteiques surazotes, et produits obtenus par ce procede |
| KR100266752B1 (ko) * | 1997-08-07 | 2001-03-02 | 오종석 | 인체 구강내 치태형성을 억제하는 신규한 유산균 |
| IT1306716B1 (it) * | 1999-06-21 | 2001-10-02 | Mendes S U R L | Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori. |
| US20020044926A1 (en) * | 1999-12-10 | 2002-04-18 | Gregor Reid | Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| SE0003100D0 (sv) * | 2000-09-01 | 2000-09-01 | Probi Ab | New strains |
| US6403084B1 (en) * | 2000-11-03 | 2002-06-11 | Pioneer Hi-Bred International, Inc. | Mixed cultures for improved fermentation and aerobic stability of silage |
| ITMI20040357A1 (it) * | 2004-02-27 | 2004-05-27 | Anidral Srl | Metodo per ridurre ler aflatossine nei mangimi nelle carni nel latte e derivati e composizione atta allo scopo |
| KR101203193B1 (ko) * | 2004-12-23 | 2012-11-20 | 악티알 파마수티카 엘디에이. | 질의 질병을 확인하고 치료하기 위한 장치 및 방법 |
| KR100780030B1 (ko) * | 2006-05-16 | 2007-11-30 | (주)다손 | 식물성 유산균 또는 바실러스균을 이용한 콩 발효음료의제조방법 |
| KR100866504B1 (ko) * | 2008-09-23 | 2008-11-11 | 주식회사 비티씨 | 홍삼 발효용 미생물 및 발효 홍삼을 함유하는 식품 조성물 |
| SG171930A1 (en) * | 2008-12-16 | 2011-07-28 | Nestec Sa | Compositions and methods for improved oral health |
-
2010
- 2010-08-18 EP EP10173286A patent/EP2420580A1/en not_active Withdrawn
-
2011
- 2011-08-17 DK DK11749151.4T patent/DK2606155T3/en active
- 2011-08-17 WO PCT/EP2011/064173 patent/WO2012022773A1/en not_active Ceased
- 2011-08-17 MX MX2013001656A patent/MX346458B/es active IP Right Grant
- 2011-08-17 AU AU2011290705A patent/AU2011290705B2/en active Active
- 2011-08-17 EP EP11749151.4A patent/EP2606155B1/en active Active
- 2011-08-17 JP JP2013524449A patent/JP5879349B2/ja active Active
- 2011-08-17 ES ES11749151.4T patent/ES2655913T3/es active Active
- 2011-08-17 BR BR112013003761-0A patent/BR112013003761B1/pt active IP Right Grant
- 2011-08-17 RU RU2013111767/10A patent/RU2584610C2/ru active
- 2011-08-17 US US13/817,378 patent/US9511102B2/en active Active
- 2011-08-17 CN CN201180050284.XA patent/CN103298924B/zh active Active
-
2015
- 2015-05-05 US US14/703,949 patent/US9192634B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2013111767A (ru) | 2014-09-27 |
| AU2011290705A1 (en) | 2013-02-07 |
| BR112013003761A2 (pt) | 2016-05-31 |
| US20150273000A1 (en) | 2015-10-01 |
| CN103298924A (zh) | 2013-09-11 |
| EP2606155B1 (en) | 2017-10-18 |
| BR112013003761B1 (pt) | 2021-06-01 |
| RU2584610C2 (ru) | 2016-05-20 |
| US9511102B2 (en) | 2016-12-06 |
| US9192634B2 (en) | 2015-11-24 |
| CN103298924B (zh) | 2016-02-03 |
| MX2013001656A (es) | 2013-03-20 |
| MX346458B (es) | 2017-03-22 |
| JP5879349B2 (ja) | 2016-03-08 |
| JP2013535226A (ja) | 2013-09-12 |
| WO2012022773A1 (en) | 2012-02-23 |
| EP2606155A1 (en) | 2013-06-26 |
| AU2011290705B2 (en) | 2014-09-11 |
| WO2012022773A9 (en) | 2012-05-24 |
| DK2606155T3 (en) | 2018-01-22 |
| EP2420580A1 (en) | 2012-02-22 |
| US20130209374A1 (en) | 2013-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2655913T3 (es) | Composición probiótica para la salud oral | |
| Stamatova et al. | Probiotics: health benefits in the mouth. | |
| KR101648992B1 (ko) | 입냄새 예방 및/또는 치료를 위한 용도 및 방법 | |
| Teughels et al. | Probiotics and oral healthcare | |
| ES2934687T3 (es) | Cepas bacterianas probióticas para la prevención y el tratamiento de enfermedades en la cavidad oral | |
| CN115803005A (zh) | 减轻口腔生态失调和促进生态平衡的益生元和益生菌治疗 | |
| KR20160096158A (ko) | 모발 품질 개선을 위한 경구 투여용 다중불포화 지방산 기반 및 카로티노이드 기반 조성물 | |
| CN109414465B (zh) | 益生菌组合物及其用途 | |
| Tahmourespour | Probiotics and the reduction of dental caries risk | |
| Agrawal et al. | Role of'live microorganisms'(probiotics) in prevention of caries: Going on the natural way towards oral health | |
| Grover et al. | Probiotics–the nano soldiers of oral health | |
| EP4483889A1 (en) | Postbiotic composition for oral administration for preventing or treating oral dysbiosis | |
| Vedam et al. | Biotherapeutic potential of lactobacillus probiotic strains on Streptococcus mutans biofilm in dental caries-pathogenesis revisited | |
| Nadelman et al. | The effect of probiotics on oral health | |
| US20240307467A1 (en) | Matrix formulated with probiotics for use in the treatment of caries | |
| Sohi et al. | Probiotics and oral health a review | |
| Acharya | Probiotics: current knowledge update | |
| TW202428292A (zh) | 用以維持口腔內環境或牙齦之健康之組合物 | |
| Ou et al. | Evaluating microbial regulation as a preventive strategy for radiation-related caries: A review | |
| Patel et al. | Probiotics and its implication in Oral health | |
| Henna | Effect of SM-18 Probiotics on Streptococcus Mutans Strain: An in Vivo Study | |
| Mani et al. | Probiotics: Eat What You Like And Let The Food Fight It Out Inside | |
| Kaur et al. | Probiotics and Dental Caries: A Review | |
| HK1259878B (zh) | 口腔内环境改善用组合物 | |
| BRPI0914726B1 (pt) | Composições cosmética, farmacêutica e de alimento ou ração compreendendo um microrganismo e uso do referido microrganismo |